Insulin aspart in patients with gestational diabetes mellitus and pregestational diabetes mellitus.

macrosomia was seen in 15.6% of human insulin group, 12.1% in insulin lispro group and 9.6% in insulin aspart group and data did not reach statistical significance.[ 14 ] The incidence of macrosomia was 12.7% in a study conducted in South India with GDM patient treated with insulin lispro.[ 15 ] The reported incidence of macrosomia in pre-GDM women was 5.2–8.9% in Asian Americans by National Centre for health statistics.[ 16 ] The present study reports that much lesser incidence of macrosomia compared to historical data.

also in 111,027 other papers